[HTML][HTML] Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
RA Droeser, C Hirt, CT Viehl, DM Frey… - European journal of …, 2013 - Elsevier
BACKGROUND: Programmed cell death 1 (PD-1) receptor triggering by PD ligand 1 (PD-
L1) inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
L1) inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
RA Droeser, C Hirt, CT Viehl, DM Frey… - European Journal of …, 2013 - infona.pl
Programmed cell death 1 (PD-1) receptor triggering by PD ligand 1 (PD-L1) inhibits T cell
activation. PD-L1 expression was detected in different malignancies and associated with …
activation. PD-L1 expression was detected in different malignancies and associated with …
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.
RA Droeser, C Hirt, CT Viehl, DM Frey… - European Journal of …, 2013 - europepmc.org
Background Programmed cell death 1 (PD-1) receptor triggering by PD ligand 1 (PD-L1)
inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
[引用][C] Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
RA Droeser, C Hirt, CT Viehl, DM Frey… - European Journal of …, 2013 - cir.nii.ac.jp
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.
RA Droeser, C Hirt, CT Viehl, DM Frey… - European journal of …, 2013 - sonar.ch
MATERIALS AND METHODS A tissue microarray (n= 1491) including healthy colon mucosa
and clinically annotated colorectal cancer (CRC) specimens was stained with two PD-L1 …
and clinically annotated colorectal cancer (CRC) specimens was stained with two PD-L1 …
[引用][C] Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
RA DROESER, C HIRT, M ZUBER… - European journal of …, 2013 - pascal-francis.inist.fr
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
RA Droeser, C Hirt, CT Viehl, DM Frey… - European Journal of …, 2013 - ejcancer.com
Background Programmed cell death 1 (PD-1) receptor triggering by PD ligand 1 (PD-L1)
inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
RA Droeser, C Hirt, CT Viehl, DM Frey… - European journal of …, 2013 - boris.unibe.ch
BACKGROUND Programmed cell death 1 (PD-1) receptor triggering by PD ligand 1 (PD-L1)
inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
RA Droeser, C Hirt, CT Viehl, DM Frey… - European journal of …, 2013 - edoc.unibas.ch
BACKGROUND: Programmed cell death 1 (PD-1) receptor triggering by PD ligand 1 (PD-
L1) inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
L1) inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
RA Droeser, C Hirt, CT Viehl… - … journal of cancer …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Programmed cell death 1 (PD-1) receptor triggering by PD ligand 1 (PD-L1)
inhibits T cell activation. PD-L1 expression was detected in different malignancies and …
inhibits T cell activation. PD-L1 expression was detected in different malignancies and …